Literature DB >> 25086091

Clostridium difficile infection: clinical challenges and management strategies.

Pamela R Walters1, Brian S Zuckerbraun2.   

Abstract

Clostridium difficile has become the leading cause of nosocomial diarrhea in adults. A substantial increase has occurred in morbidity and mortality associated with disease caused by C difficile and in the identification of new hypervirulent strains, warranting a high clinical index of suspicion for infections due to this organism. Prevention of infection requires a multidisciplinary approach, including early recognition of disease, effective contact isolation precautions, adherence to disinfectant policies, and judicious use of antibiotics. Current treatment approaches are based on the severity of illness. As hypervirulent strains evolve, unsuccessful treatments are more common. Complicated colitis caused by C difficile may benefit from surgical intervention. Subtotal colectomy and end ileostomy have been the procedures of choice, but are associated with a high mortality rate because of late surgical consultation and use of surgery as a salvage therapy. A promising surgical alternative is creation of a diverting loop ileostomy with colonic lavage. ©2014 American Association of Critical-Care Nurses.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25086091     DOI: 10.4037/ccn2014822

Source DB:  PubMed          Journal:  Crit Care Nurse        ISSN: 0279-5442            Impact factor:   1.708


  5 in total

1.  Impact of Clostridium difficile toxin gene PCR result on decisions to de-isolate patients: Do the ends justify the means?

Authors:  Kirsti A Morris; Kerrie Davies; Mark H Wilcox
Journal:  J Infect Prev       Date:  2018-02-16

2.  Evaluation of the novel artus C. difficile QS-RGQ, VanR QS-RGQ and MRSA/SA QS-RGQ assays for the laboratory diagnosis of Clostridium difficile infection (CDI), and for vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) screening.

Authors:  K A Morris; L R Macfarlane-Smith; M H Wilcox
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-16       Impact factor: 3.267

3.  A prospective study of two isothermal amplification assays compared with real-time PCR, CCNA and toxigenic culture for the diagnosis of Clostridium difficile infection.

Authors:  Martina Neuendorf; Raquel Guadarrama-Gonzalez; Birgit Lamik; Colin R MacKenzie
Journal:  BMC Microbiol       Date:  2016-02-12       Impact factor: 3.605

4.  A case report of successful management of clostridium difficile colitis with antegrade Fidaxomicin through a mucous fistula obviating the need for subtotal colectomy.

Authors:  Suzanne Arnott; Matthew Skancke; Sheena Chen; Bruce Abell
Journal:  Int J Surg Case Rep       Date:  2017-11-27

5.  Factors Favouring the Development of Clostridium Difficile Infection in Critically Ill Patients.

Authors:  Bianca-Liana Grigorescu; Raluca Ştefania Fodor; Adrian Dan Cioc; Mihaly Veres; Monica Orlandea; Bogdan Lăzescu; Emoke Almasy
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-02-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.